Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use
Complications of the intrathecal route may cause potential toxicity related to the medical device and properties of the administered drug and/or excipient. A description of clinical and histological effects of polyethylene glycol and miripirium after Depo-Medrol injection, and the adverse reactions of particulate methylprednisolone acetate was conducted. The safety of the intrathecal route with excipients, label and off-label drugs is discussed.
A bibliographic search in Medline, Google, and Cochrane database from 1940 to June 2016 was performed. The keywords included ‘intrathecal methylprednisolone acetate’, ‘miripirium’, ‘myristyl-gamma-picolinium’, ‘side effects’, ‘intrathecal Depo-Medrol’, ‘polyethylene glycol’, and ‘intrathecal devices’ used individually or in combination.
Adverse reactions have been reported with this intrathecal administration route such as arachnoiditis, bladder dysfunction, headache, meningitis. Some pharmaceutical excipients have been associated with specific toxicity issues and with allergic and anaphylaxis reactions. Additives of methylprednisolone acetate formulations such as polyethylene glycol and miripirium chloride can be neurotoxic when injected intrathecally. Polyethylene glycol—an antimicrobial agent widely used in pharmaceutical drugs—has been associated with cardiovascular, hepatic, respiratory, and CNS toxicity.
Intrathecal methylprednisolone acetate (Depo-Medrol) therapy seems not fully safe due to reported adverse events. The use of other forms of corticosteroid therapy free from excipients should be emphasized such as soluble methylprednisolone sodium succinate.
KeywordsDrug safety Intrathecal injection Methylprednisolone acetate Off-label
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Onofrio BM, Yaksh TL, Arnold PG (1981) Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc 56:516–520Google Scholar
- 5.Varhabhatla NC, Zuo Z (2012) Rising complication rates after intrathecal catheter and pump placement in the pediatric population: analysis of national data between 1997 and 2006. Pain Phys 15(1):65–74Google Scholar
- 8.Motta F, Antonello CE (2016) Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications. J Neurosurg Pediatr 24:1–6Google Scholar
- 16.Sehgal AD, Gardner WJ (1963) Place of intrathecal methylprednisolone acetate in neurological disorders. Trans Am Neurol Assoc 88:275–276Google Scholar
- 19.Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A (1999) Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg Anesth Pain Med 24:287–293Google Scholar
- 21.Pinkel D, Woo S (1994) Prevention and treatment of meningeal leukemia in children. Blood 84(2):355–366Google Scholar
- 22.Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E et al (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children’s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children’s Oncology Group. Blood 108(4):1165–1173CrossRefGoogle Scholar
- 23.National Institute of Cancer (2016) Les spécificités des cancers des enfants et des adolescents. Available at: http://www.e-cancer.fr/Professionnels-de-sante/L-organisation-de-l-offre-de-soins/Cancerologie-pediatrique/Les-specificites-des-cancers-des-enfants-et-des-adolescents. Accessed June 2016
- 25.Donadieu J, Auclerc MF, Baruchel A, Leblanc T, Landman-Parker J, Perel Y et al (1998) Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle Group. French Acute Lymphoblastic Leukaemia Study Group. Br J Haematol 102(3):729–739CrossRefGoogle Scholar
- 26.Donadieu J, Auclerc MF, Baruchel A, Perel Y, Bordigoni P, Landman-Parker J et al (2000) Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE). Br J Cancer 83(12):1617–1622CrossRefGoogle Scholar
- 28.Pui CH, Mahmoud HH, Rivera GK, Hancock ML, Sandlund JT, Behm FG et al (1998) Early intensification of intrathecal chemotherapy virtually eliminates central nervous system relapse in children with acute lymphoblastic leukemia. Blood 92(2):411–415Google Scholar
- 30.Gardner WJ, Goebert HW, Sehgal AD (1961) Intraspinal corticosteroids in the treatment of sciatica. Trans Am Neurol Assoc 86:214–215Google Scholar
- 31.Goldstein NP, McGuckin WF, McKenzie BF, Mattox VR (1970) Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis. Trans Am Neurol Assoc 95:243–244Google Scholar
- 34.Roche J (1984) Steroid-induced arachnoiditis. Med J Aust 140(5):281–284Google Scholar
- 35.Johnson A, Ryan MD, Roche J (1991) Depo-Medrol and myelographic arachnoiditis. Med J Aust 155(1):18–20Google Scholar
- 37.Lima RM, Navarro LH, Carness JM, Barros GA, Marques ME, Solanki D et al (2010) Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs. Pain Phys 13(5):493–501Google Scholar
- 39.Food and Drug Administration (FDA) (2016) Depo-Medrol label information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/011757s103lbl.pdf. Accessed June 2016
- 41.Zemel E, Loewenstein A, Lazar M, Perlman I (1993) The effects of myristyl gamma-picolinium chloride on the rabbit retina: morphologic observations. Invest Ophthalmol Vis Sci 34(7):2360–2366Google Scholar
- 43.Loewenstein A, Zemel E, Lazar M, Perlman I (1991) The effects of Depo-Medrol preservative on the rabbit visual system. Invest Ophthalmol Vis Sci 32(12):3053–3060Google Scholar
- 45.Knezevic NN, Candido KD, Cokic I, Krbanjevic A, Berth SL, Knezevic I (2014) Cytotoxic effect of commercially available methylprednisolone acetate with and without reduced preservatives on dorsal root ganglion sensory neurons in rats. Pain Phys 17(5):E609–E618Google Scholar
- 52.Donaldson K, Stone V (2003) Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita 39(3):405–410Google Scholar
- 53.Driscoll KE, Carter JM, Hassenbein DG, Howard B (1997) Cytokines and particle-induced inflammatory cell recruitment. Environ Health Perspect 105:1159–1164Google Scholar
- 55.Golightly LK, Smolinske SS, Bennett ML, Sutherland EW, Rumack BH (1988) Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I). Med Toxicol Adverse Drug Exp 3(2):128–165Google Scholar
- 57.No authors listed (2009) What are excipients doing in medicinal products? Drug Ther Bull 47(7):81–84Google Scholar
- 61.Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA et al (2016) Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study. Hematol Oncol. https://doi.org/10.1002/hon.2342 (epub ahead of print) Google Scholar
- 62.Safari F, Aminnejad R, Mohajerani SA, Farivar F, Mottaghi K, Safdari H (2016) Intrathecal dexmedetomidine and fentanyl as adjuvant to bupivacaine on duration of spinal block in addicted patients. Anesth Pain Med 31 6(1):26714Google Scholar
- 63.Tandon S, Singh S, Sharma S, Lahiri AK (2016) Use of intrathecal fluorescein in recurrent meningitis after cochlear implantation. Iran J Otorhinolaryngol 28(86):221–226Google Scholar
- 65.Raza SM, Banu MA, Donaldson A, Patel KS, Anand VK, Schwartz TH (2016) Sensitivity and specificity of intrathecal fluorescein and white light excitation for detecting intraoperative cerebrospinal fluid leak in endoscopic skull base surgery: a prospective study. J Neurosurg 124(3):621–626CrossRefGoogle Scholar
- 75.Gurun MS, Leinbach R, Moore L, Lee CS, Owen MD, Eisenach JC (1997) Studies on the safety of glucose and paraben-containing neostigmine for intrathecal administration. Anesth Analg 85(2):317–323Google Scholar